Cargando…
Changing use of antidiabetic drugs in the UK: trends in prescribing 2000–2017
OBJECTIVES: Guidelines for the use of drugs for type 2 diabetes mellitus (T2DM) have changed since 2000, and new classes of drug have been introduced. Our aim was to describe how drug choice at initiation and first stage of intensification have changed over this period, and to what extent prescribin...
Autores principales: | Wilkinson, Samantha, Douglas, Ian, Stirnadel-Farrant, Heide, Fogarty, Damian, Pokrajac, Ana, Smeeth, Liam, Tomlinson, Laurie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067400/ https://www.ncbi.nlm.nih.gov/pubmed/30056393 http://dx.doi.org/10.1136/bmjopen-2018-022768 |
Ejemplares similares
-
Comparative effects of sulphonylureas, dipeptidyl peptidase‐4 inhibitors and sodium‐glucose co‐transporter‐2 inhibitors added to metformin monotherapy: a propensity‐score matched cohort study in UK primary care
por: Wilkinson, Samantha, et al.
Publicado: (2020) -
Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care
por: Wilkinson, Samantha, et al.
Publicado: (2018) -
A systematic review comparing the evidence for kidney function outcomes between oral antidiabetic drugs for type 2 diabetes
por: Wilkinson, Samantha V., et al.
Publicado: (2018) -
Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004–2014
por: Mathur, Rohini, et al.
Publicado: (2017) -
Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study
por: Bidulka, Patrick, et al.
Publicado: (2021)